pCEP4-gp120(BaL)-CD4
(Plasmid
#98957)
-
PurposeMammalian expression plasmid for CD4-fused gp120 from HIV-1 BaL isolate
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 98957 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCEP4
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 10393
- Total vector size (bp) 12601
-
Vector typeMammalian Expression
-
Selectable markersHygromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameHIV-1 (BaL) gp120
-
Alt nameEnv
-
SpeciesHuman immunodeficiency virus 1
-
Insert Size (bp)2208
-
MutationCodon-optimized synthetic gene
-
GenBank IDAAA44191.1
- Promoter CMV
-
Tags
/ Fusion Proteins
- CD5 leader sequence (N terminal on insert)
- CD4 (domains D1-D2) (C terminal on insert)
- avi tag for enzymatic biotinylation (C terminal on insert)
- FLAG epitope tag (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer CMV_fwd
- 3′ sequencing primer EBV_rev (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCEP4-gp120(BaL)-CD4 was a gift from Erik Procko (Addgene plasmid # 98957 ; http://n2t.net/addgene:98957 ; RRID:Addgene_98957) -
For your References section:
Mapping Interaction Sites on Human Chemokine Receptors by Deep Mutational Scanning. Heredia JD, Park J, Brubaker RJ, Szymanski SK, Gill KS, Procko E. J Immunol. 2018 Apr 20. pii: jimmunol.1800343. doi: 10.4049/jimmunol.1800343. 10.4049/jimmunol.1800343 PubMed 29678950